Sunday, October 25, 2020

your download link will expire

INO.com

The below offer is brought to you by our associates at Profits Run

Dear Edward,

If you still haven't downloaded my free "Simple Options Trading For Beginners" guide...

...please take a few seconds and download it right now before your download link expires.

I eventually plan to charge money for this training, so do yourself a favor and download it now...

That way, no matter what it costs in the future, you'll have a free copy on your computer.

Make sense?

Free: Simple Options Trading For Beginners << Download Now

Good Trading,
Bill Poulos
Profits Run, Inc.

p.s. Go here to save a copy of "Simple Options Trading For Beginners" to your computer while it's still free, and before I start charging for it.

To accept this special invitation, click here.

 
Indexes Snapshot
Symbol Last Change %
Dow Jones Industrial Average 28335.57 -28.09 -0.10%
NASDAQ Composite 11548.28 +42.27 +0.38%
S&P 500 3465.39 +11.90 +0.35%
SPDR S&P 500 345.57 +0.96 +0.28%
iShares Russell 2000 ETF 163.03 +0.90 +0.59%
U.S. STOCK INDEXES

The Dow closed lower on Friday but pared early session losses on news that talks on another financial aid package were gaining very little traction in Congress, which raised investor fears that the plan would not be implemented before Election Day. The mid-range close sets the stage for a steady to slightly lower opening when Monday's night session begins trading. Stochastics and the RSI are neutral to bearish signaling that sideways to lower prices remain possible near-term. Closes below the 50-day moving average crossing at 28,020.51 would signal that a short-term top has been posted. If the Dow renews the rally off September's low, September's high crossing at 29,199.35 is the next upside target. First resistance is October's high crossing at 28,957.90. Second resistance is September's high crossing at 29,199.35. First support is the 50-day moving average crossing at 28,020.51. Second support is the 25% retracement level of the March-September-rally crossing at 26,464.30.

The December NASDAQ 100 posted an inside day with a higher close on Friday. The high-range close sets the stage for a steady to higher opening when Monday's night session begins trading. Stochastics and the RSI remain neutral to bearish signaling that sideways to lower prices are possible near-term. Closes below the 50-day moving average crossing at 11,510.50 are needed to confirm that a short-term top has been posted. If December renews the rally off September's low, September's high crossing at 12,465.25 is the next upside target. First resistance is October's high crossing at 12,197.00. Second resistance is September's high crossing at 12,465.25. First support is the 50-day moving average crossing at 11,510.50. Second support is October's low crossing at 10,204.50.

The December S&P 500 closed higher on Friday. The high-range close sets the stage for a steady to higher opening when Monday's night session begins trading. Stochastics and the RSI are neutral to bearish signaling that sideways to lower prices are possible near-term. Closes below the 50-day moving average crossing at 3395.98 would confirm that a short-term top has been posted. If December renews the rally off September's low, September's high crossing at 3516.60 is the next upside target. First resistance is October's high crossing at 3498.10. Second resistance is September's high crossing at 3516.60. First support is the 50-day moving average crossing at 3395.98. Second support is the October 2nd low crossing at 3304.70.



Thank you!

Thank you for subscribing to Market Commentary from INO.com.

You can modify your email preferences or unsubscribe here.

INO.com, Inc. | 228 Park Avenue South, Suite 320 | New York, New York 10003

U.S. Government Required Disclaimer - Commodity Futures Trading Commission Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results

These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.

All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation.

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...